Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter. T50.905A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM T50.905A became effective on October 1, 2018.
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter. T44.3X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code Description T88.6 Anaphylactic shock due to the adverse effect of a drug T88.7 Unspecified adverse effect of a drug N14.1 Nephropathy induced by drugs, medicaments and biological substances D59.0 Drug-induced autoimmune hemolytic anemia D59.2 Drug-induced non-autoimmune hemolytic anemia D61.1 Drug-induced aplastic anemia J70.4
T50.905A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Adverse effect of unsp drug/meds/biol subst, init. The 2020 edition of ICD-10-CM T50.905A became effective on October 1, 2019.
ICD-10 code T88. 7 for Unspecified adverse effect of drug or medicament is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
ICD 10 codes for anticholinergics and ICD Code Y51. 3.
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug (T36-T50).
v58. 69 is what we use for medication management.
Anticholinergic syndrome results from competitive antagonism of acetylcholine at central and peripheral muscarinic receptors. Central inhibition leads to an agitated (hyperactive) delirium - typically including confusion, restlessness and picking at imaginary objects - which characterises this toxidrome.
Anticholinergic syndrome may be caused by intentional overdose, inadvertent ingestion, medical noncompliance, or geriatric polypharmacy. Systemic effects also have resulted from topical eye drops. Anticholinergic syndrome commonly follows the ingestion of a wide variety of prescription and over-the-counter medications.
If the patient was taking the Coumadin correctly and it was correctly prescribed, this is an adverse effect. The manifestation of the Coumadin toxicity would be the principal diagnosis followed by a code to capture the cause of the adverse effect.
Underdosing of other drugs, medicaments and biological substances, initial encounter. T50. 996A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
For underdosing, assign the code from categories T36 – T50 found in Chapter 19. These codes require a 7th character extension to describe an initial encounter (A), subsequent encounter (D), or sequela encounter (S). Underdosing codes must be identified in the following order: The medical condition is sequenced first.
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The patient's primary diagnostic code is the most important. Assuming the patient's primary diagnostic code is Z76. 89, look in the list below to see which MDC's "Assignment of Diagnosis Codes" is first.
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.